These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 28409389)
21. Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra. Sun XC; Ren XF; Chen L; Gao XQ; Xie JX; Chen WF J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):94-103. PubMed ID: 26455404 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model. He Q; Li YH; Guo SS; Wang Y; Lin W; Zhang Q; Wang J; Ma CG; Xiao BG Eur J Neurosci; 2016 Jan; 43(1):41-52. PubMed ID: 26565388 [TBL] [Abstract][Full Text] [Related]
23. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity. Zhang D; Hu X; Wei SJ; Liu J; Gao H; Qian L; Wilson B; Liu G; Hong JS J Neuroinflammation; 2008 May; 5():21. PubMed ID: 18507839 [TBL] [Abstract][Full Text] [Related]
24. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions. Zhang F; Shi JS; Zhou H; Wilson B; Hong JS; Gao HM Mol Pharmacol; 2010 Sep; 78(3):466-77. PubMed ID: 20554604 [TBL] [Abstract][Full Text] [Related]
25. Gallic Acid Attenuated LPS-Induced Neuroinflammation: Protein Aggregation and Necroptosis. Liu YL; Hsu CC; Huang HJ; Chang CJ; Sun SH; Lin AM Mol Neurobiol; 2020 Jan; 57(1):96-104. PubMed ID: 31832973 [TBL] [Abstract][Full Text] [Related]
26. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways. Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G Int Immunopharmacol; 2019 Oct; 75():105739. PubMed ID: 31351366 [TBL] [Abstract][Full Text] [Related]
27. Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/ TLR4/ NF-κB pathways in BV2 cells. Zhang J; Zheng Y; Luo Y; Du Y; Zhang X; Fu J Mol Immunol; 2019 Dec; 116():29-37. PubMed ID: 31590042 [TBL] [Abstract][Full Text] [Related]
28. Apocyanin, NADPH oxidase inhibitor prevents lipopolysaccharide induced α-synuclein aggregation and ameliorates motor function deficits in rats: Possible role of biochemical and inflammatory alterations. Sharma N; Kapoor M; Nehru B Behav Brain Res; 2016 Jan; 296():177-190. PubMed ID: 26367469 [TBL] [Abstract][Full Text] [Related]
29. Peiminine Protects Dopaminergic Neurons from Inflammation-Induced Cell Death by Inhibiting the ERK1/2 and NF-κB Signalling Pathways. Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Liu D; Fu S Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534526 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide-induced neurotoxicity. Zhang F; Qian L; Flood PM; Shi JS; Hong JS; Gao HM J Pharmacol Exp Ther; 2010 Jun; 333(3):822-33. PubMed ID: 20190013 [TBL] [Abstract][Full Text] [Related]
31. Modulation of M1/M2 polarization by capsaicin contributes to the survival of dopaminergic neurons in the lipopolysaccharide-lesioned substantia nigra in vivo. Bok E; Chung YC; Kim KS; Baik HH; Shin WH; Jin BK Exp Mol Med; 2018 Jul; 50(7):1-14. PubMed ID: 29968707 [TBL] [Abstract][Full Text] [Related]
32. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats. Lee EY; Lee JE; Park JH; Shin IC; Koh HC Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585 [TBL] [Abstract][Full Text] [Related]
33. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation. Iravani MM; Leung CC; Sadeghian M; Haddon CO; Rose S; Jenner P Eur J Neurosci; 2005 Jul; 22(2):317-30. PubMed ID: 16045485 [TBL] [Abstract][Full Text] [Related]
34. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease. Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275 [TBL] [Abstract][Full Text] [Related]
35. Ginsenoside Rb1 protects dopaminergic neurons from inflammatory injury induced by intranigral lipopolysaccharide injection. Li DW; Zhou FZ; Sun XC; Li SC; Yang JB; Sun HH; Wang AH Neural Regen Res; 2019 Oct; 14(10):1814-1822. PubMed ID: 31169200 [TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease. Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-1 receptor antagonist reduces neonatal lipopolysaccharide-induced long-lasting neurobehavioral deficits and dopaminergic neuronal injury in adult rats. Pang Y; Tien LT; Zhu H; Shen J; Wright CF; Jones TK; Mamoon SA; Bhatt AJ; Cai Z; Fan LW Int J Mol Sci; 2015 Apr; 16(4):8635-54. PubMed ID: 25898410 [TBL] [Abstract][Full Text] [Related]
38. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice. Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000 [TBL] [Abstract][Full Text] [Related]
39. Progressive loss of nigrostriatal dopaminergic neurons induced by inflammatory responses to fipronil. Park JH; Park YS; Koh HC Toxicol Lett; 2016 Sep; 258():36-45. PubMed ID: 27313094 [TBL] [Abstract][Full Text] [Related]